Скачать или смотреть "Inside the Pharmaceutical Analytical Testing Outsourcing Boom – Market Breakdown"

Pharmaceutical analytical testing outsourcing refers to the practice of pharmaceutical companies contracting third-party laboratories or specialized service providers to perform analytical testing on drug products, raw materials, intermediates, and finished pharmaceuticals.

Pharmaceutical Analytical Testing Outsourcing Market Overview
The global pharmaceutical analytical testing outsourcing market size was valued at USD 2,636.1 million in 2023 and is projected to grow from USD 2,809.9 million in 2024 to USD 4,677.4 million by 2031, exhibiting a CAGR of 7.55% during the forecast period.

This market is driven by the increasing demand for high-quality, cost-effective testing services in drug development and manufacturing. Outsourcing analytical testing helps pharmaceutical companies reduce operational costs, access specialized expertise, and speed up the time-to-market for new drugs.

Major companies operating in the pharmaceutical analytical testing outsourcing industry are Charles River Laboratories, Eurofins Scientific, Intertek Group plc, SGS Société Générale de Surveillance SA, Pace, WuXi AppTec Co., Ltd., Labcorp, West Pharmaceutical Services, Inc., ICON plc, Thermo Fisher Scientific Inc., Cambrex Corporation, Novo Holdings A/S, AptarGroup, Inc., Pharmaron, and Dr. Reddy’s Laboratories Ltd.

Unlock the full report with detailed trends, forecasts, and competitive insights here:https://www.kingsresearch.com/pharmac...